Редактирование:
CASK
Перейти к навигации
Перейти к поиску
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
Peripheral plasma membrane protein CASK (EC 2.7.11.1) (hCASK) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog) [LIN2] ==Publications== {{medline-entry |title=Integrated study on comparative transcriptome and skeletal muscle function in aged rats. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29325930 |abstract=The present study aimed to reveal aging-related changes in the skeletal muscle of SD rats by comparing transcriptome analysis, integrated with muscle physiological parameters. Ten rats aged 25 months were set as the old group (OG) and ten rats aged 6 months were set as the young group (YG). After 6 weeks of feeding, the body mass, grip strength, and gastrocnemius muscle mass were determined, and the differentially expressed genes were analyzed by transcriptome sequencing, followed by GO enrichment analysis and KEGG analysis. The results showed that the muscle index and the relative grip strength were lower in OG rats than YG rats. The expressions of AMPK, [[UCP3]], IGF-1, several ion channel associated genes and collagen family genes were down-regulated in OG rats. [[MGMT]], one of the strength determining genes and CHRNa1, a subunit of the acetylcholine receptor were up-regulated in OG rats. The present results supply the global transcriptomic information involved in aging related skeletal muscle dysfunction in rats. The reduced expressions of AMPK, IGF-1, and [[CASK]] can explain the losses of muscle mass and function in the aged rats. In addition, the up-regulation of [[MGMT]] and CHRNa1 also contribute to muscle wasting and weakness during aging. |mesh-terms=* Aging * Animals * Male * Muscle Proteins * Muscle, Skeletal * Rats * Rats, Sprague-Dawley * Transcriptome |keywords=* Gene expression * Grip strength * RNA-Seq technology * Sarcopenia |full-text-url=https://sci-hub.do/10.1016/j.mad.2018.01.001 }} {{medline-entry |title=Neurexins 1-3 Each Have a Distinct Pattern of Expression in the Early Developing Human Cerebral Cortex. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28013231 |abstract=Neurexins (NRXNs) are presynaptic terminal proteins and candidate neurodevelopmental disorder susceptibility genes; mutations presumably upset synaptic stabilization and function. However, analysis of human cortical tissue samples by RNAseq and quantitative real-time PCR at 8-12 postconceptional weeks, prior to extensive synapse formation, showed expression of all three NRXNs as well as several potential binding partners. However, the levels of expression were not identical; [[[[NRXN1]]]] increased with age and [[[[NRXN2]]]] levels were consistently higher than for [[[[NRXN3]]]]. Immunohistochemistry for each NRXN also revealed different expression patterns at this stage of development. [[[[NRXN1]]]] and [[[[NRXN3]]]] immunoreactivity was generally strongest in the cortical plate and increased in the ventricular zone with age, but was weak in the synaptogenic presubplate (pSP) and marginal zone. On the other hand, [[[[NRXN2]]]] colocalized with synaptophysin in neurites of the pSP, but especially with [[GAP43]] and [[CASK]] in growing axons of the intermediate zone. Alternative splicing modifies the role of NRXNs and we found evidence by RNAseq for exon skipping at splice site 4 and concomitant expression of KHDBRS proteins which control this splicing. [[[[NRXN2]]]] may play a part in early cortical synaptogenesis, but NRXNs could have diverse roles in development including axon guidance, and intercellular communication between proliferating cells and/or migrating neurons. |mesh-terms=* Aging * Calcium-Binding Proteins * Cell Adhesion Molecules, Neuronal * Cerebral Cortex * Embryonic Development * Female * Gene Expression Regulation, Developmental * Humans * Infant * Male * Nerve Tissue Proteins * Neural Cell Adhesion Molecules * Neurogenesis * Tissue Distribution |keywords=* cortical development * neurexins * neurodevelopmental disorders * subplate |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654756 }} {{medline-entry |title=Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein [[CASK]]/LIN-2 during rat brain development. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/10460248 |abstract=The syndecan family of cell surface heparan sulfate proteoglycans interacts via their cytoplasmic C-terminal tail with the PDZ domain of [[CASK]]/LIN-2, a membrane-associated guanylate kinase homolog. The syndecan-[[CASK]] interaction may be involved in intercellular signaling and/or cell adhesion. Here we show that syndecan-1 to syndecan-4 have distinctive mRNA distributions in adult rat brain by in situ hybridization, with syndecan-2 and -3 being the major syndecans expressed in neurons of the forebrain. At the protein level, syndecan-2 and -3 are differentially localized within neurons; syndecan-3 is concentrated in axons, whereas syndecan-2 is localized in synapses. The synaptic accumulation of syndecan-2 occurs late in synapse development. [[CASK]] is a cytoplasmic-binding partner for syndecans, and its subcellular distribution changes strikingly during development, shifting from a primarily axonal distribution in the first 2 postnatal weeks to a somatodendritic distribution in adult brain. This change in [[CASK]] distribution correlates temporally and spatially with the expression patterns of syndecan-3 and -2, consistent with the association of both of these syndecans with [[CASK]] in vivo. In support of this, we were able to coimmunoprecipitate a complex of [[CASK]] and syndecan-3 from brain extracts. Our results indicate that specific syndecans are differentially expressed in various cell types of the brain and are targeted to distinct subcellular compartments in neurons, where they may serve specialized functions. Moreover, [[CASK]] is appropriately expressed and localized to interact with both syndecan-2 and -3 in different compartments of the neuron throughout postnatal development. |mesh-terms=* Aging * Amino Acid Sequence * Animals * Brain * COS Cells * Embryonic and Fetal Development * Gene Expression Regulation, Developmental * Heparan Sulfate Proteoglycans * Immunohistochemistry * Membrane Glycoproteins * Molecular Sequence Data * Neurons * Proteoglycans * RNA, Messenger * Rats * Recombinant Proteins * Sequence Alignment * Sequence Homology, Amino Acid * Subcellular Fractions * Synapses * Syndecan-1 * Syndecan-2 * Syndecan-3 * Syndecan-4 * Syndecans * Transcription, Genetic * Transfection |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6782500 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)
Навигация
Персональные инструменты
Вы не представились системе
Обсуждение
Вклад
Создать учётную запись
Войти
Пространства имён
Статья
Обсуждение
русский
Просмотры
Читать
Править
История
Ещё
Навигация
Начало
Свежие правки
Случайная страница
Инструменты
Ссылки сюда
Связанные правки
Служебные страницы
Сведения о странице
Дополнительно
Как редактировать
Вики-разметка
Telegram
Вконтакте
backup